Fetterman appealed to President Trump and Health and Human Services Secretary Robert F. Kennedy Jr. personally.

In a New York Times column this week, the Pennsylvania Democrat shared his experience taking Mounjaro while advocating for ...

Medicare Advantage updates while halting proposed anti-obesity drug coverage, impacting millions of potential beneficiaries.

The CMS has opted not to move forward with a plan that would have extended Medicare coverage to obesity drugs for millions of ...

Democrat senators are begging Health and Human Services Secretary (HHS) Robert F. Kennedy Jr. to keep a proposed Biden-era rule pertaining to obesity drugs. In November, the […] ...

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...

The Trump administration announced Friday it will not move forward with plans to cover popular weight-loss drugs under ...

People who have tried other methods to lose weight have found results from obesity drugs that ‘feel like magic.’ ...

Popular weight loss drugs may do more than curb appetite — they may also help reduce the risk of dementia, according to new research.

Semaglutide brand names include Ozempic, Rybelus, and Wegovy ... and sauces may slightly increase a person's risk of type 2 ...